dm+d
426801002
Articles
Preparing to use eculizumab biosimilar
6 March 2024
Refrigerated Storage
SolirisAlexion Pharma UK
Alexion Pharma UK
Soliris
300 mg concentrate for solution for infusion (10 mg/ml)
In the event of an inadvertent temperature excursion the following data may be used:
Soliris vials in the original package may be removed from refrigerated storage for only one single period of up to 3 days. At the end of this period the product can be put back in the refrigerator.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Contact Alexion for additional information on cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Not required
2 March 2021
London MI Service
Lactation Safety Information
Limited published evidence of safety
No eculizumab detected in breast milk and no long-term effects noted in breastfed infants
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
17 September 2018